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MicroRNAs (miRs) are small noncoding RNAs which control the expression of target genes 
by either translational repression or RNA degradation, known as canonical miR functions. The 
recent discovery that miR-328 has a noncanonical function and can activate gene expression 
by antagonizing the activity of heterogeneous ribonuclear protein E2 (hnRNP E2) opens an 
unexplored and exciting field of gene expression regulation. The global importance of such 
noncanonical miR function is not yet known. In order to achieve a better understanding of 
the  new miR activity, we performed a compartment specific tandem mass tag (TMT)-based 
proteomic analysis in differentiated MonoMac6 (MM6) cells, to monitor gene expression 
variations in response to miR-328 knockdown. We identified a broad spectrum of novel 
potential miR-328/hnRNP E2 and miR-328 targets involved in regulation of compartment 
specific cellular processes, such as inflammation or RNA splicing. This study provides first 
insights of the global significance of noncanonical miR function.
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INTRODUCTION
MicroRNAs (miRs) are a family of small noncoding RNAs of about 21–24 nucleotides that regulate 
a wide spectrum of cellular biological processes including inflammation and cancerogenesis (Croce, 
2009; Ochs et al., 2011; Ochs et al., 2014). To date, more than 2,500 miRs have been identified 
(http://www.mirbase.org) while the function of many miR remains unclear.
MiRs are generated by enzymatic processes from precursor transcripts and assembled with the RNA 
interference silencing complex (RISC). Then, they are directed to their binding sites in the 3′ untranslated 
region (UTR) of the target messenger RNA (mRNA) and mediate either translational repression or 
degradation of their target transcript (Croce, 2009; Ochs et al., 2011; Ochs et al., 2014). It has long been 
a dogma that miRs loaded in RISCs bind to their target mRNA through specific base pairing thereby 
reducing gene expression at posttranscriptional level. However, there is recent evidence that miRs are 
also able to activate gene expression via a novel miR function described as noncanonical function. 
MiRs can bind to RNA binding proteins (RBPs) sequestering them away from their target mRNAs 
in a RISC independent manner (Eiring et al., 2010). Such a function was described for the first time 
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for miR-328. It acts as an RNA decoy to the heterogeneous nuclear 
ribonucleoprotein E2 (hnRNP E2), a global posttranscriptional 
regulator (Eiring et al., 2010; Saul et al., 2016). Recently, we found 
that apart from its function as translational repressor, hnRNP E2 
can bind to C-rich sequences within 5´UTR located introns acting 
as splicing regulator in monocytes (Saul et al., 2016). During 
myeloid cell differentiation, miR-328 is significantly induced and 
antagonizes hnRNP E2 activity which results in the upregulation 
of hnRNP E2 target genes. One representative gene controlled by 
the hnRNP E2/miR-328 balance is the calcium binding protein 
S100A9 which plays an important role in cell differentiation, 
inflammatory response and oxidative stress response of monocytes. 
During monocyte maturation, miR-328 increases reactive oxygen 
species (ROS) production as well as adhesion and migration ability 
of monocytes by modulating the monocytic surface marker cluster 
of differentiation molecule 11 (CD11b). Recently, we were able to 
attribute this effect to the novel noncanonical miR-328 function 
(Saul et al., 2016). Overall, these discoveries reveal intriguing novel 
functions of miRs and open up a yet unexplored and exciting field 
of miR research. In order to achieve a better understanding of the 
dual activity of miR-328, we performed a quantitative tandem mass 
tags (TMT)-based proteomic study in differentiated MonoMac6 
(MM6) cells to monitor gene expression variations in response to 
miR-328 knockdown. This study identified a broad spectrum of 
novel potential miR-328/hnRNP E2 and miR-328 targets involved 
in important cellular processes such as inflammation, p53 signalling 
or mRNA splicing. For the first time our results give an impression 
of the global significance and distribution of the noncanonical miR-
328 function which will facilitate new strategies in miR research.
MATERIALS AND METHODS
Cell Culture
MonoMac6 (MM6) cells were obtained from DSMZ (DSMZ 
no. ACC124) and grown in RPMI-1640 medium supplemented 
with 10% (v/v) fetal calf serum (FCS, Biochrom AG), 100 μg/ml 
streptomycin (PAA), 100 U/ml penicillin (PAA), 1× non essential 
amino acids (Sigma Aldrich), 10 μg/ml insulin, 1 mM oxaloacetate 
(AppliChem), and 1 mM sodium pyruvate (PAA). Cell culture 
was carried out in a humidified atmosphere of 5% CO2 at 37°C. 
MM6 cells were differentiated with 1 ng/ml TGFβ (PeproTech) 
and 50 nM calcitriol (Sigma Aldrich) at 37°C, 6% CO2. HeLa 
cells were obtained from DSMZ (DSMZ no. ACC57). They 
were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) FCS, 100 μg/ml streptomycin, and 
100 U/ml penicillin. Cell culture was carried out in a humidified 
atmosphere of 5% CO2 at 37°C.
miR-328 Knockdown in MM6 Cells
As previously described in Saul et al. (2016), we used 2 pmol/
μl of a 3′-cholesterol-tagged ON TARGET siRNA-miR-328 
(GGGAGAAAGUGCAUACAGC-3′-Chl) or control siRNA 
(5′-UCUCUCACAACGGGCAUUU-3′-Chl), which was directly 
added to MM6 cell culture medium. Both siRNAs were synthesized 
by GE Dharmacon. The efficiency of miR-328 knockdown was 
assessed by quantitative polymerase chain reaction (qPCR) 
in 4  days differentiated MM6 cells and revealed a knockdown 
efficiency of around 85% for both biological replicates, which were 
used for proteomics study.
Fraction Preparation
The soluble and microsomal fractionation was performed as 
previously described in (Ochs et al., 2013; Saul et al., 2016). The 
protein content in Western blot samples was determined by 
Bradford assay (BioRad Laboratories), for proteomics samples 
the protein amount was determined by Pierce BCA Protein Assay 
(Thermo Fisher Scientific) following manufacturer’s instructions.
Trypsin Digestion and TMT Labeling
Twenty-five micrograms of protein were taken from microsomal 
and soluble fraction, respectively, and subjected to disulfide 
reduction by addition of 5 μl of DTT of 200 mM DTT (Sigma 
Aldrich) in 100 mM NH4HCO3 (Carl Roth) for 30 min at 56°C. 
The sulfhydryl alkylation was performed by adding 4 μl of 1 M 
iodoacetamide (Sigma Aldrich) in 100 mM NH4HCO3 at room 
temperature for 1 h in a dark room. Trypsin (modified sequencing 
grade, Promega) was added (1:30, trypsin/protein), and the samples 
were incubated at 37°C overnight. Tandem Mass Tag™ 6-plex 
(TMTsixplex™) Isobaric Label Reagents (ThermoFisher Scientific) 
were used for peptide labeling according to the instruction by the 
manufacturer. As internal standards we pooled 10 µg of each soluble 
and microsomal fraction and 25 µg of total pool were labeled with 
TMTsixplex™ label reagent 130 and 131, respectively. All separately 
labeled samples were pooled into final two TMT sets, one containing 
soluble fractions and one containing microsomal fraction. Excess 
TMTsixplex™ reagent was removed from the pooled samples using 
an SCX-cartridge (StrataSCX, Phenomenex), and the eluates were 
dried in SpeedVac. Next, we performed peptide prefractionation 
as described in Cao et al. (2012). Briefly, TMT-labeled protein 
digests were separated over a 45-min gradient (3–55% B) on a 
2.1 × 250 mm XBridge BEH300 C18 column (Waters) at the flow 
rate of 200 µl/min. A- and B-buffers consisted of 20 mM ammonia 
in MilliQ-grade water and 20 mM ammonia in 80% acetonitrile 
(ACN), respectively. Fractions were collected per minute and the 
fractions covering the peptide elution range were combined into 
12 final fraction. Obtained fractions were evaporated in SpeedVac 
and stored at −20°C until Liquid chromatography tandem mass 
spectrometry (LC-MS/MS) analysis.
Mass Spectrometry
Online LC-MS was performed using a hybrid Q-Exactive 
mass spectrometer (ThermoFisher Scientific). Samples were 
trapped on an Acclaim™ PepMap™ 100 C18 desalting column 
(ThermoFisher Scientific), and separated on a 50-cm-long EASY-
spray column (50  cm × 75 μm ID, PepMap RSLC C18, 2-μm 
particles, 100-Å pore size, ThermoFisher Scientific) installed on 
to the EASY-Spray Series ion source. Solvent A was 97% water, 
3% ACN, 0.1% formic acid; and solvent B was 5% water, 95% 
acetonitrile, 0.1% formic acid. At a constant flow of 0.25 μl min−1, 
the curved gradient went from 2% B up to 48% B in 55  min, 
followed by a steep increase to 100% B in 5 min. FTMS master 
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scans with 70,000 resolution (and mass range 400–1,200 m/z) 
were followed by data-dependent MS/MS (17,500 resolution) on 
the top 10 ions using higher-energy collision dissociation (HCD) 
at 31% normalized collision energy. Precursors were isolated 
with a 2  m/z window. Automatic gain control (AGC) targets 
were 3e6 for MS1 and 2e5 for MS2. Maximum injection times 
were 250 ms for MS1 and 200 ms for MS2. The entire duty cycle 
lasted ~2.5  s. Dynamic exclusion was used with 20-s duration. 
Precursors with unassigned charge state or charge state 1 were 
excluded. An underfill ratio of 1% was used.
Data Analysis
Acquired MS raw files were searched using Sequest-Percolator 
under the software platform Proteome Discoverer 1.4.1.14 
(Thermo Fisher Scientific) against human Uniprot database 
(release 01.12.2015) and filtered to a 1% FDR cutoff. We used a 
precursor ion mass tolerance of 10 ppm, and product ion mass 
tolerances of 0.02 Da for HCD-FTMS and 0.8 Da for CID-ITMS. 
The algorithm considered tryptic peptides with maximum two 
missed cleavages; carbamidomethylation (C), TMT 6-plex (K, 
N-term) as fixed modifications, and oxidation (M) as dynamic 
modifications. Quantification of reporter ions was done by 
Proteome Discoverer on HCD-FTMS tandem mass spectra 
using an integration window tolerance of 10 ppm. Only unique 
peptides in the data set were used for quantification. Biological 
context and molecular networks were analyzed by Ingenuity 
Pathway Analysis (Ingenuity Systems, www.ingenuity.com) and 
STRING database platform (Szklarczyk et al., 2017).
Western Blotting
Western blot analysis was performed as previously described 
(Ochs et al., 2013). The membranes were incubated with primary 
antibodies that recognize TLR2 (D7G9Z, Cell signaling), NOX2 
(611414, BD Bioscience), β-actin (sc1616, Santa Cruz), HMGB1 
antibody (2G7, mouse IgG2b, noncommercial antibody), S100A9 
(ab63818, Abcam), and secondary near infrared dye-conjugated 
secondary antibodies (IRDye, Li-COR Bioscience). Visualization 
and quantitative analysis were carried out with an Odyssey Infrared 
Imaging System (LICOR Biosciences). Odyssey NEWBLOT Nitro 
Stripping buffer (LI-COR Biosciences) was used for membrane 
stripping according to manufacturer’s instructions.
Plasmid Constructs
The luciferase reporter gene constructs containing either the 
NOX2- or the TLR2 3’UTR were constructed by standard 
restriction ligation. The 3’UTR was PCR amplified from cDNA out 
of MM6 cells by Q5 polymerase (New England Biolabs). For the 
amplification of the NOX2 3’UTR the oligonucleotides NOX_NotI_
fwd (5’-AAAAAGCGGCCGCCTTGTCTCTTCCATGAGGAA-3’) 
and NOX_HindIII_rev (5’-AAAAAAAGCTTGAAAGCTCATTC 
ATTTTAATAG-3’) were used. The TLR2 3’UTR was amplified by 
using the oligonucleotides TLR2_fwd (5’-GGCCGCGTTCCCAT 
ATTTAAG-3’) and TLR2_rev (5’-AGCTTTTCTCATCCTGTAA 
AG-3’). The oligonucleotides contained the restriction sites NotI 
and HindIII to clone the DNA fragments into the vector pDLAAG 
(kindly provided by J. Weigand, TU Darmstadt) (Kemmerer and 
Weigand, 2014) downstream of the luc2 gene. To verify miR-328 
binding the seed region was mutated in both 3’UTRs. The mutated 
NOX2 3’UTR was constructed by site-directed mutagenesis and 
Golden Gate (GG) Assembly. Therefore, two DNA fragments were 
created by PCR using the primer pair NOX2_GG-fwd (5’-ACTG 
GAAGACTCAATTTCATTAAGGCCAAGAAGGGC-3’) and 
NOX2_mut-rev (5’-ACTGGAAGACCTGCTGTATTAGTAAAC 
TGGAGTATGCTC-3’) and the primer pair NOX2_mut-fwd 
(5’-CTGGAAGACCTCAGCGCTGTAACTGCCTTGGATGTT 
CTTTCTACAGAAGAATATTGG-3’) and NOX2_GG-rev (5’-ACT 
GGAAGACTC GATC CACT T TGGGCAGGAAAT TAG 
TCTGC-3’). The two DNA fragments were Golden Gate cloned 
(Engler et al., 2008) into the vector pJBL2807-empty, a for Golden 
Gate Assembly modified version of pJBL2807 vector (Chappell et al., 
2015). Afterward, the mutated NOX2 3’UTR was PCR amplified 
(NOX2_mut-fwd and NOX2-rev: 5’-TAAGGGCTAGCTGGA 
GAAGACCACT T TGGGCAGGAAAT TAGTCTGC-3’) 
and cloned into the vector pDLAAG by standard restriction 
ligation using the unique restriction sites NotI and NheI. 
To create a modified TLR2 3’UTR with a mutated miR-328 
binding site, an overlap extension PCR with two fragments was 
performed with the oligonucleotides 3’UTR-fwd (5’-TCAT 
TAAGGCCAAGAAGGGC-3’) and TLR2_mut-rev (5’-GCCA 
G T T G C TA C A G AT TA C A G T C A AT C C C T TATATA 
CATGGGTTCTGCATCCATGAAG-3’) for fragment 1 and the 
oligonucleotides TLR2_mut-fwd (5’-ATGTATATAAGGGATTG 
ACTGTAATCTGTAGCAACTGGC-3’) and 3UTR-rev (5’-TGT 
GGTATGGCTGATTATGATCC-3’) for fragment 2. Afterward, 
the two fragments were used for an overlap extension PCR 
containing the oligonucleotides 3’UTR-fwd and 3’UTR-rev. 
The DNA fragment was cloned into the vector pDLAAG by 
standard restriction ligation using the unique restriction sites 
NotI and HindIII. All plasmids and sequences are available 
upon request.
Transfection of miR-328 Mimic
Twenty-four hours prior to transfection, HeLa cells were 
seeded at a density of 5×105 per well in a six-well plate; 5 nmol 
MISSION® miR-328 mimics (HMI0483, Sigma Aldrich) or 
negative control (HMC0002, Sigma Aldrich) was transfected 
using Lipofectamine 2000® (Invitrogen) according to the 
manufacturer’s instructions. The transfection efficiency was 
determined by qPCR according to Saul et al. (2016).
Luciferase Reporter Gene Assay
Twenty-four hours prior to transfection, 4×104 HeLa cells per 
well were seeded in 24-well plates; 400 ng/well of TLR2 or NOX2 
constructs and 5 nmol miR-328 mimics and control mimics were 
used for transfection with Lipofectamine 2000® (Invitrogen) 
according to the manufacturer’s instructions. After 24  h, cells 
were assayed for luciferase activity using the Dual-Glo™ Stop and 
Glow Luciferase Assay System (Promega) with a TECAN infinite 
M200 reader. Renilla luciferase activity was used to normalize 
the luciferase activity to the transfection efficacy.
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Statistics
Results are given as mean + SEM of minimum three independent 
experiments. Statistical analysis was carried out by Student’s 
paired or unpaired t test (two-tailed). Differences were considered 
as significant for p < 0.05 (indicated as *p < 0.05, **p < 0.01) 
using GraphPad Prism 5.0.
RESULTS
Analysis of Protein Expression Changes 
in Response to miR-328 Knockdown  
in MM6 Cells
To investigate changes in the proteome in response to miR-328 
knockdown, a TMT-based proteomics approach was carried 
out in MM6 cells treated with TGFβ and calcitriol for 4 days 
(Figure 1). Soluble and microsomal fractions were prepared 
from differentiated MM6 cells as previously described (Eriksson 
et al., 2008; Saul et al., 2016). After digestion, individual peptide 
fractions were labeled using TMT 6-plex, which enables a highly 
sensitive multiplex analysis, is time efficient, and controls for 
technical variations (Sandberg et al., 2014). TMT quantification 
was performed by measuring the intensities of fragment reporter 
ions released from the labels in the tandem MS mode (MS2) 
during peptide fragmentation. Precursor ions were selected in 
the full scan mode (MS1) to be fragmented. To identify overall 
trends in protein expression, we applied two different setups of the 
TMT-based proteomics approach to detect expression variations 
of proteins localized in both, microsomal and soluble fraction, 
and to investigate whether the sample composition influences the 
outcome of the proteomics study. On the one hand, we pooled all 
TMT labeled samples and analyzed them by MS, and on the other 
hand, we analyzed separately TMT-labeled samples of the soluble 
and microsomal fraction, respectively. In the pooled proteomics 
setup, we identified and quantified 4,981 proteins in both the 
soluble and the microsomal fraction, consisting of two or more 
peptides (confidence level ≥ 99%). In the separated setup, we were 
able to quantify 3,112 proteins in the soluble fraction and 3,105 
proteins in the microsomal fraction with a confidence level ≥ 99%. 
Overall, we set the criteria for downregulation to a TMT ratio ≤ 0.77 
(fold change <−1.3) and upregulation was determined with a TMT 
ratio of ≥ 1.3 (fold change 1.3). In the pooled proteomics setup, we 
identified in the soluble fraction 171 upregulated proteins (3.4% 
of all quantified proteins) and 180 downregulated proteins (3.6% 
of all quantified proteins) in response to miR-328 knockdown. In 
the separated setup, 375 of all quantified proteins were increased 
(12%) and only 41 (1.3% proteins) were downregulated in the 
soluble fraction upon miR knockdown. Only 2% (61 proteins) 
of all proteins were upregulated in the microsomal fraction and 
4% decreased in response to the miR-328 knockdown (Figure 2). 
A comparison of proteins analyzed in both experimental setups 
revealed that the majority of the proteins were identified in both 
proteomics approaches, but to a lower extent in the separated 
proteomics setup. Moreover, it is noticeable that the expression 
levels between the two proteomics setups are significantly different. 
Thus, it is possible that a protein [e.g., high mobility group box 1 
(HMGB1)] is noted as downregulated in one proteomics setup, but 
in the other proteomics setup it is noted as unregulated in response 
to the miR knockdown (Figure 2).
Overall, our results show that on average the miR-328 regulates 
5% of all analyzed proteins. Yet the distribution of the miR-328 
regulated proteins differ strongly depending on the setup of the 
MS analytic, which indicates that sample content influences the 
TMT reporter ion-based proteomics analysis.
Identification of Novel miR-328 and  
miR-328/hnRNP E2 Target Genes
Using bioinformatical approaches, we aimed to identify possible 
novel miR-328 and miR-328/hnRNP E2 decoy targets. As a 
FIGURE 1 | Experimental schema for the tandem mass tags (TMT) based proteomics study. MM6 cells were treated either with 2 pmol/µl control siRNA or  
miR-328 siRNA and differentiated for 4 days with 1 ng/ml TGFβ and 50 nM calcitriol. Soluble and microsomal fractions were prepared and each fraction was 
digested with trypsin. The peptides were labelled with TMT reagents. Pooled setup: Samples from microsomal and soluble fraction were mixed together and 
analyzed simultaneously by LC-MS/MS. Separated setup: Samples from microsomal and soluble fraction were analyzed separately by LC-MS/MS.
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potential canonical target for miR-328, we determined proteins 
that were upregulated in response to miR-328 knockdown and 
revealed a potential seed region within their 3´UTR. We predicted 
the possible binding sequence for miR-328 using miR target 
prediction tool “microRNA.org” (http:www.microrna.org) (Betel 
et al., 2008). A protein that was downregulated by the miR-328 
knockdown was determined as a potential noncanonical miR-
328 target, if it covers a potential hnRNP E2 binding site within 
its 5´UTR or 5´UTR intron according to Eiring et al. (2010) and 
Saul et al. (2016). We downloaded the corresponding 5´UTR 
sequences of the certain proteins from the database “UCSC 
Genome Browser” (https://genome.ucsc.edu/) (Kent et  al., 
2002) and analyzed these by using the online tool “SpliceAid 2” 
to identify potential hnRNP E2 binding motifs (www.introni.it/
spliceaid.html) (Piva et al., 2012).
Although different potential canonical and noncanonical 
miR-328 targets were identified in the separated as well as in 
the pooled proteomics setup, the ratios of the potential miR-
328 and miR-328/hnRNP E2 target genes were nearly the same. 
We could show that ~21% of the upregulated proteins were 
FIGURE 2 | Number of proteins differentially expressed after miR-328 knockdown detected in 4d differentiated MM6 cells (downregulated ≤ −1.3 ratio; upregulated ≥ 1.3 
ratio). (A) Pooled proteomics setup. (B) Separated proteomics setup. Number of total quantified proteins and the number of potential hnRNP E2 and miR-328 targets are 
indicated above.
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potential canonical targets of miR-328. Approximately 36% 
of the downregulated proteins contain a putative hnRNP E2 
binding site which represents potential novel, noncanonical 
targets of miR-328. S100A9, the only confirmed target for 
miR-328 and hnRNP E2 in MM6 cells (Saul et al., 2016), was 
detected in our proteomics study as a potential noncanonical 
miR-328 target, supporting the validity of our proteomics data. 
In Tables S1 and S2 all potential canonical and noncanonical 
miR-328 targets are listed.
Pathway Analysis of miR-328 Regulated 
Proteins
Next, we analyzed all miR-328 regulated proteins in soluble 
as well as microsomal fraction from both proteomics setups 
using Ingenuity Pathway Analysis (Ingenuity Systems, www.
ingenuity.com). We predicted the five most affected canonical 
pathways in response to miR-328 knockdown. The canonical 
pathways with p-values <0.05 were defined as significant. The 
analysis revealed that the eukaryotic initiation factor 2 (eIF2) 
signaling, regulation of eukaryotic initiation factor 4 (eIF4) and 
70-kDa ribosomal S6 kinase (p70S6K) signaling, mitochondrial 
dysfunction, protein ubiquitination pathway, and mTOR 
signaling are the most affected canonical pathways by miR-
328 knockdown (Table 1). We further analyzed all identified 
potential canonical and noncanonical miR-328 targets merged 
from both proteomics by STRING database (Szklarczyk et  al., 
2017) to create an interacting protein network. Based on this 
data set, an enrichment of Gene Ontology (GO) analysis was 
performed to predict which biological processes, cellular 
compartments, and molecular functions are most affected by 
miR-328. The results of our GO functional enrichment analysis 
are listed in Table S3 for all potential miR-328 targets and in 
Table S4 for all noncanonical miR-328 targets. Our results show 
that both the canonical and the noncanonical miR-328 functions 
regulate different processes in monocytes in a compartment-
specific manner. It should be noted that metabolic processes, 
e.g., single-organism metabolic process or inflammation-related 
processes like toll-like receptor 2 (TLR2) signaling pathway, 
is regulated by the canonical miR-328 function in the soluble 
fraction. In the microsomal fraction, such enrichment was not 
observed. Here, we recognized that enzymatic reactions seem 
to be most affected by the canonical miR function. On the 
contrary, the noncanonical miR-328 function regulates another 
spectrum of cellular processes. The formation of extracellular 
vesicles termed as exosomes, RNA binding functions, and 
proteins associated with the receptor for advanced glycation end 
products (RAGE) like HMGB1 and S100A9, seem to be affected 
by the noncanonical miR-328 function in the microsomal 
fraction. In the soluble fraction, mRNA processing processes, 
e.g. mRNA splicing, are mostly affected.
Validation of the Proteomic Data Using 
Western Blot Analysis
In order to validate the proteomics results, different potential 
canonical and noncanonical miR-328 targets of biological 
interest were selected to be subjected to Western blot analysis. 
As potential noncanonical miR-328 target, we have chosen 
HMGB1, which was downregulated in microsomal fraction 
by miR-328 knockdown and harbors a potential hnRNP E2 
binding site, like S100A9, the known hnRNP E2/miR-328 
target (Saul et al., 2016). Both proteins were analyzed by 
Western blot (Figure 3A and  B). We would like to note that 
the expression level of S100A9 in soluble fraction was very low 
(Figure 3B), but overall, the results validated the proteomics 
data of the pooled setup (Table S2).
As potential canonical miR-328 targets, we selected 
NADPH oxidase 2 (NOX2, CYBB) and TLR2. NOX2 and 
TLR2 were both upregulated in the soluble fraction in 
response to miR-328 knockdown (Table S1). Furthermore, 
both genes contain putative binding sites for miR-328 
within their 3´UTR (Figure 4A and B). The Western blot 
analysis of NOX2 validated our proteomics results in the 
soluble fraction. Again, NOX2 expression was upregulated 
in response to miR-328 knockdown (Figure 3C). However, 
the sensitivity of the Western blot analysis was too low to 
detect any NOX2 expression in the microsomal fraction. 
Furthermore, we also validated TLR2 as a potential canonical 
miR-328 target. Analysis was done in both the soluble and 
microsomal fraction, in which TLR2 expression was strongly 
upregulated in response to miR-328 knockdown. Of note, we 
found TLR2 mainly expressed in microsomal, but less in the 
soluble fraction (Figure 3D). We further performed Western 
blot analysis of tumor protein p53 (p53) Figure 3E, since it 
was predicted as one of the top upstream regulators inhibited 
upon miR-328 knockdown as shown by Ingenuity Pathway 
TABLE 1 | Five most significantly affected canonical pathways by miR-328 
knockdown predicted using IPA (Ingenuity Pathway Analysis software, Ingenuity 
Systems, www.ingenuity.com). A) Pooled proteomics setup. B) Separated 
proteomics setup. 
Proteomics setup Top canonical pathways p-value
A) Pooled
Soluble fraction eIF2 Signaling 1.33E−48
Regulation of eIF4 and p70S6K Signaling 1.16E−32
Mitochondrial Dysfunction 3.19E−28
Protein Ubiquitination Pathway 2.46E−27
mTOR Signaling 2.31E−23
Microsomal fraction eIF2 Signaling 1.33E−48
Regulation of eIF4 and p70S6K Signaling 1.16E−32
Mitochondrial Dysfunction 3.19E−28
Protein Ubiquitination Pathway 2.46E−27
mTOR Signaling 2.31E−23
B) Separated
Soluble fraction eIF2 Signaling 9.79E−56
Regulation of eIF4 and p70S6K Signaling 1.90E−35
Protein Ubiquitination Pathway 5.23E−26
Mitochondrial Dysfunction 1.49E−23
mTOR Signaling 1.40E−20
Microsomal fraction eIF2 Signaling 9.79E−56
Regulation of eIF4 and p70S6K Signaling 2.12E−36
Mitochondrial Dysfunction 1.84E−35
Protein Ubiquitination Pathway 1.72E−30
mTOR Signaling 4.53E−26
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Analysis. Bioinformatical analysis revealed a potential 
binding site for hnRNP E2 within its 5´UTR intron, similar to 
S100A9 and HMGB1 which indicates that p53 could represent 
a novel miR-328/hnRNP E2 target. As predicted, we detected 
a significant downregulation of p53 expression in response to 
miR-328 knockdown in the soluble fraction of differentiated 
MM6 cells which supports our hypothesis that p53 could be a 
new noncanonical miR-328 target gene. Overall, our Western 
blot results demonstrate that the expression of the selected 
proteins were consistent with our TMT-based quantitative 
proteomics study which confirms the accuracy of our data.
Validation of Novel Canonical miR-328 
Targets
TLR2 and NOX2 were selected for further validations as novel 
canonical miR-328 targets. The 3´UTR of each gene, harboring 
a potential seed region of miR-328 (Figure 4A and B), was 
amplified by PCR and cloned downstream of the luciferase 
open reading frame in the pDLAAG vector (Kemmerer and 
Weigand, 2014). The constructs were cotransfected with 
miR-328 mimics into HeLa cells. The overexpression was 
previously monitored by qPCR and revealed an approximately 
60-fold upregulation (Figure 4C). The luciferase activity was 
significantly reduced by both constructs in response to miR-
328 overexpression (Figure 4D and E). When the potential 
miR-328 binding sites were mutated (Figure 4A and B), the 
effect of miR-328 knockdown was abolished (Figure 4D and 
E). Overall, our results indicate that TLR2 and NOX2 are 
direct targets of miR-328.
DISCUSSION
Numerous publications have shown that miRs are one of the 
most important posttranscriptional gene expression regulators 
involved in a variety of biological and physiological processes. 
The general understanding is that miRs bind sequences 
related to their target mRNA and mediate either translational 
repression or degradation of the mRNA transcript (Croce, 
FIGURE 3 | Validation of proteomics results using Western blot analysis of A) HMGB1, B) S100A9, C) NOX2, D) TLR2, and E) p53 in differentiated MM6 cells with 
and without knockdown of miR-328 (ΔmiR-328). β-Actin was used as the loading control. The relative changes in ΔmiR-328 samples to control were set as 1 and 
given as mean + SEM of three independent experiments, except S100A9 expression was analyzed in soluble fraction in four independent experiments, *p < 0.05, 
**p < 0.01.
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2009; Ochs et  al., 2011; Ochs et al., 2014). In the last few 
years, other miR functions have been discovered that lead to 
an activation of gene expression, e.g. by antagonizing RNA-
binding protein activities (Eiring et al., 2010; Saul et al., 2016) 
or by binding to receptors such as TLR 7/8 (Fabbri et al., 2012). 
Of note, only a handful of publications describe such new 
noncanonical functions. This stands in sharp contrast to the 
thousands of publications that describe the canonical function 
of miRs. This discrepancy could be explained by the various 
online prediction tools which makes it rather easy to find a 
binding site within a 3´UTR and thus a new canonical miR 
target. Nonetheless, this should not obscure the importance 
of these noncanonical miR functions. Rather, it should be 
an incentive to find new miR–protein interactions and to 
investigate their global significance more closely.
In order to characterize the global role of the noncanonical 
miR-328 function, we conducted a stable isotope label-based 
proteomics study to identify new canonical and noncanonical 
target genes of miR-328 in differentiated MM6 cells and 
correlate them to their biological function. Subcellular 
fractionation was applied for comparison of proteins in soluble 
and microsomal compartment (Ochs et al., 2013). Based on 
our previous studies, we know that the decoy mechanism 
occurs mainly in the microsomal fraction (Saul et al., 2016) 
which indicates that the translational efficiency is modulated 
mainly on the ER (Ochs et  al., 2013). Furthermore, we used 
two different proteomics setups to span technical variations. 
Overall, the knockdown of miR-328 leads to a variety of changes 
in the expression rate of different proteins. Using bioinformatic 
approaches, we were able to identify proteins that are directly 
regulated by miR-328 and miR-328/hnRNP E2, respectively, 
and exclude proteins that were indirectly regulated. Thus, we 
were able to identify and validate NOX2 and TLR2 as new 
direct miR-328 targets. It is noteworthy that only about 1/5 of 
the proteins upregulated by the knockdown have a potential 
seed sequence for miR-328. This suggests that miR-328 might 
influence protein expression in other noncanonically ways. In 
fact, a high number of downregulated proteins in response to 
miR-328 knockdown contain a potential hnRNP E2 binding 
site within their 5´UTR or 5´UTR intron which indicates 
FIGURE 4 | Validation of TLR2 and NOX2 as canonical miR-328 target. Putative miR-328 binding site within the 3´UTR of (A) TLR2 wild type (WT) and (B) NOX2 
WT. Nucleotides mutated for the luciferase reporter gene assays are marked in red. (C) Quantification of miR-328 overexpression (miR-328 oe) in HeLa cells using 
qPCR. Activity of luciferase reporter gene constructs containing (D) TLR2 WT or TLR2 WT 3´UTR and (E) NOX2 WT or NOX2 mut 3´UTR. The relative luciferase 
activities are normalized to corresponding oe control. Data are shown as the mean + SEM of minimum three independent experiments. *p < 0.05.
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that these proteins are regulated by the noncanonical miR-
328 function. We identified for example HMGB1 and p53 as 
novel potential miR-328/hnRNP E2 targets which needs to be 
further confirmed in the future. But it is not only the number 
of regulated proteins that indicate that the noncanonical 
function of miR-328 has a greater global impact than initially 
expected. First pathway analysis supports this impression. They 
demonstrate that both potential miR functions regulate cellular 
processes in a compartment-specific manner. It should be 
emphasized that in the microsomal fraction, the extracellular 
vesicle formation and RAGE signaling are influenced, while 
in the soluble fraction, mRNA splicing is regulated by the 
noncanonical miR-328 function. This stands in contrast to 
the canonical function which affects mostly inflammatory and 
single organism metabolic processes in the soluble fraction. 
Of note, specific mechanistic investigations need to be done 
in order to validate the individual target genes, which were 
predicted in our proteomics approach.
Overall, our results demonstrate that the canonical and 
noncanonical miR-functions specifically regulate different 
cellular processes. It will be of interest in the future to find 
out how the balance between canonical and noncanonical 
miR-328 functions is regulated. Our data suggest that the 
physiological significance of the noncanonical function of 
the miR-328 is comparable to that of the known canonical 
miR-function.
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